Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities
Net income	$ 3,838	$ 3,594
Adjustments to net income:
Depreciation	1,381	1,092
Amortization of capitalized software	61	53
Stock compensation	338	309
Gains on sales of assets	0	(126)
Deferred taxes	(134)	(189)
Increase (decrease) from changes in:
Accounts receivable	(343)	(75)
Inventories	(302)	(297)
Prepaid expenses and other current assets	2	(69)
Accounts payable and accrued expenses	57	38
Accrued compensation	(134)	(127)
Income taxes payable	168	487
Changes in funded status of retirement plans	(14)	2
Other	(19)	(372)
Cash flows from operating activities	4,899	4,320
Cash flows from investing activities
Capital expenditures	(3,625)	(3,628)
Proceeds from U.S. CHIPS and Science Act (CHIPS Act) incentives	335	0
Proceeds from asset sales	1	194
Purchases of short-term investments	(2,644)	(8,807)
Proceeds from short-term investments	5,198	8,461
Other	(28)	(36)
Cash flows from investing activities	(763)	(3,816)
Cash flows from financing activities
Proceeds from issuance of long-term debt	1,199	2,980
Repayment of debt	(750)	(300)
Dividends paid	(3,709)	(3,555)
Stock repurchases	(1,074)	(392)
Proceeds from common stock transactions	358	430
Other	(49)	(42)
Cash flows from financing activities	(4,025)	(879)
Net change in cash and cash equivalents	111	(375)
Cash and cash equivalents at beginning of period	3,200	2,964
Cash and cash equivalents at end of period	3,311	2,589
Supplemental cash flow information
Investment tax credit (ITC) used to reduce income taxes payable	246	532
Proceeds from CHIPS Act incentives	335	0
Total cash benefit related to the CHIPS Act	$ 581	$ 532